Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline flips an MS project to Novartis for up to $1B
GlaxoSmithKline flips an MS project to Novartis for up to $1B
GlaxoSmithKline flips an MS project to Novartis for up to $1B
Submitted by
admin
on August 21, 2015 - 9:29am
Source:
Fierce Biotech
News Tags:
GSK
Novartis
MS
multiple sclerosis
ofatumumab
Headline:
GlaxoSmithKline flips an MS project to Novartis for up to $1B
Do Not Allow Advertisers to Use My Personal information
